- Title
- Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
- Creators - without role
- Victoria E.R. ParkerKim Keppler-Noreuil - National Human Genome Research InstituteLaurence Faivre - Centre Hospitalier Universitaire Dijon BourgogneMaxime Luu - Centre d’Investigation Clinique 1436Neal Oden - EmmesLeena de SilvaJulie Sapp - National Human Genome Research InstituteKatrina AndrewsMarc Bardou - Centre d’Investigation Clinique 1436Kong Chen - National Institute of Diabetes and Digestive and Kidney DiseasesThomas Darling - Uniformed Services University of the Health SciencesElodie Gautier - Centre Hospitalier Universitaire Dijon BourgogneBarry Goldspiel - National Institutes of Health Clinical CenterSmail Hadj-Rabia - Expression Génétique MicrobienneJulie HarrisGeorgios KounidasParag Kumar - National Institutes of Health Clinical CenterMarjorie Lindhurst - National Human Genome Research InstituteRomaric Loffroy - Centre Hospitalier Universitaire Dijon BourgogneLudovic Martin - Centre Hospitalier Universitaire d'AngersAlice Phan - Hospices Civils de LyonKristina Rother - National Institute of Diabetes and Digestive and Kidney DiseasesBrigitte Widemann - National Institutes of HealthPamela Wolters - National Institutes of HealthChristine CoubesLucile PinsonMarjolaine Willems - Département de génétique médicale, maladies rares et médecine personnalisée [CHU Montpellier]Catherine Vincent-DelormePierre Vabres - Centre Hospitalier Universitaire Dijon BourgogneRobert SempleLeslie Biesecker - National Human Genome Research Institute
- Publication Details
- Genetics in Medicine, Vol.21(5), pp.1189-1198
- Identifiers
- 9938590909311
- Academic Unit
- Institut des Neurosciences de Montpellier - INM
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-04943543
Journal article
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
Genetics in Medicine, Vol.21(5), pp.1189-1198
05/2019
Metrics
1 Record Views